Characterization of the ETO and AML1-ETO proteins involved in the 8;21 translocation in acute myelogenous leukemia

European Journal of Haematology

Volumn 60, Issue 4, 1998, Pages 217-225

  Le, Xiao Feng ^a   Claxton, David ^a   Kornblau, Steve ^a   Fan, You Hong ^a   Mu, Zhao Mei ^a   Chang, Kun Sang ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acute myeloid leukemia; AML1; ETO; Nuclear matrix; Pathogenesis

Indexed keywords

CYTARABINE; NUCLEAR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN K 562; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; ERYTHROPOIESIS; GENETIC LINKAGE; GROWTH REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0031981193     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1998.tb01027.x     Document Type: Article

References (33)

1. ROWLEY JD. Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 1990: 27: 122-136.
2. MIYOSHI H, SHIMIZU K, KOZU T, MASEKI N, KANEKO Y, OHKI M. t(8;21) on chromosome in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991: 88: 10431-10434.
3. ERICKSON PF, GAO J, CHANG K-S, et al. Identification of breakpoint in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1-ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992: 80: 1825-1831.
4. NISSON PE, WATKINS PC, SACCHI N. Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and novel gene on chromosome 8 in t(8;21) leukemic cells. Cancer Genet Cytogenet 1992: 63: 81-88.
5. MIYOSHI H, KOZU T, SHIMS K, et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993: 12: 2715-2721.
6. ERICKSON PF, ROBINSON M, OWENS G, DRABKIN HA. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res 1994: 54: 1782-1786.
7. KAGOSHIMA H, SHIGESADA K, SATAKE M, et al. The runt domain identifies a new family of heteromeric transcription regulators. Trends Genet 1993: 9: 338-341.
8. NUCIFORA G, ROWLEY JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 1995: 86: 1-14.
9. SPECK NA, STACY T. A new transcription factor family associated with human leukemias. Crit Rev Eukaryot Gene Exp 1995: 5: 337-364.
10. OKUDA T, DEURSEN J, HIEBERT SW, GROSVELD G, DOWNING JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996: 84: 321-330.
11. WANG Q, STACY T, BINDER M, MARIN-PADILLA M, SHARPE AH, SPECK NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA 1996: 93: 3444-3449.
12. LIU PP, TARLE SA, HAJRA A, et al. Fusion between transcription factor CBFb/PEBP2b and a myosin heavy chain in acute myeloid leukemia. Science 1993: 261: 1041-1044.
13. WANG Q, STACY T, MILLER JD, et al. The CBFβ subunit is essential for CBFα2 (AML1) function in vivo. Cell 1996: 87: 697-708.
14. CASTILLA LH, CISCA W, WANG Q, et al. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell 1996: 87: 687-696.
15. ERA T, ASOU N, KUNISADA T, et al. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Gene Chrom Cancer 1995: 13: 25-33.
16. FEINSTEIN PG, KORNFELD K, HOGNESS DS, MANN RS. Identification of homeotic target genes in Drosophila melanogaster including nervy, a proto-oncogene homologue. Genetics 1995: 140: 573-580.
17. + hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease. Blood 1996: 88: 1813-1823.
18. MEYERS S, LENNY N, HIEBERT SW. The t(8;21) fusion protein interferes with AML1B-dependent transcriptional activation. Mol Cell Biol 1995: 15: 1974-1982.
19. FRANK R, ZHANG J, UCHIDA H, MEYERS S, HIEBERT SW, NIMER SD. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene 1995: 11: 2667-2674.
20. SAKAKURA C, YAMAGUCHI-IWAI Y, SATAKE M, et al. Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO) specific antisense oligonucleotide. Proc Natl Acad Sci USA 1994: 91: 11723-11727.
21. ROWLEY PT, OHLSSON-WILHELM BM, FARLEY BA, LABELLA S. Inducers of erythroid differentiation in K562 human leukemia cells. Exp Hematol 1981: 9: 32-37.
22. CHANG K-S, FAN YH, STASS SA, et al. Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene 1993: 8: 983-988.
23. CHANG K-S, FAN YH, ANDREEFF M, LIU J, MU ZM. The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 1995: 85: 3646-3653.
24. LE X-F, YANG P, CHANG K-S. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J Biol Chem 1996: 271: 130-135.
25. BEREZNEY, R, COFFEY, DS. Nuclear matrix: isolation and characterization of a framework structure from rat liver nuclei. J Cell Biol 1977: 73: 616-637.
26. SACCHI N, SCHIAFFONATI L, MAGNANI I, et al. Detection and subcellular localization of an AML1 chimeric protein in the t(8;21) positive acute myeloid leukemia. Oncogene 1996: 12: 437-444.
27. BEREZNEY R, MORTILLARO MJ, MA H, WEI XY, SAMARABANDU J. The nuclear matrix: a structural milieu of genomic function. Int Rev Cytol 1995: 162A: 1-65.
28. MEYERS S, DOWNING JR, HIEBERT SW. Identification of AML1 and the (8;21) translocation protein (AML1-ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 1993: 13: 6336-6345.
29. MERRIMAN HL, VAN WIJNEN AJ, HEIBERT S, et al. The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/Runt Domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 1995: 34: 13125-13132.
30. DOWNING JR, HEAD DR, CURCIO-BRING AM, et al. An AML1-ETO fusion transcript is consistently detected by RNA-base polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 1993: 81: 2860-2865.
31. LENNY N, MEYERS S, HIEBERT SW. Functional domains of the t(8;21) fusion protein, AML1-ETO. Oncogene 1995: 11: 1761-1769.
32. FEY EG, BANGS P, SPARKS C, ODGREN P. The nuclear matrix: defining structural and functional roles. Crit Rev Eukaryot Gene Exp 1991: 1: 127-143.
33. ZENG C, VAN WIJNEN JV, STEIN JL, et al. Identification of a nuclear matritargeting signal in the leukemia and bone-related AML/CBF-α transcription factors. Proc Natl Acad Sci USA 1997: 94: 6746-6751.